Supernus Pharmaceuticals (SUPN)
(Delayed Data from NSDQ)
$32.02 USD
-0.08 (-0.25%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $31.98 -0.04 (-0.12%) 6:10 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $0.39 | -10.26% |
Earnings Summary
For their last quarter, Supernus Pharmaceuticals (SUPN) reported earnings of $0.36 per share, missing the Zacks Consensus Estimate of $0.37 per share. This reflects a negative earnings surprise of 2.70%. Look out for SUPN's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of $0.39 per share, reflecting a year-over-year increase of 234.48%.
Earnings History
Price & Consensus
Zacks News for SUPN
Supernus (SUPN) Reports Q2 Earnings: What Key Metrics Have to Say
SUPN: What are Zacks experts saying now?
Zacks Private Portfolio Services